Bluebird Bio
BLUE4.9700.00% ( 0.000 )
Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: Bluebird Bio(BLUE) the Revenue is 38.71 M (+108.4%);the EBIT is -21.51 M (+72.67%);the EPS is -2.98 (+58.77%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.04B108.43%
----
----
EBIT
-0.02B72.67%
----
----
EPS
-2.981158.77%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf